The Scene of Banned Drugs in India

Sunita Panchawat; Nupoor Sharma

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

The Scene of Banned Drugs in India

Author(s): Sunita Panchawat, Nupoor Sharma

Email(s): sunita_pharma2008@rediffmail.com

DOI: Not Available

Address: Sunita Panchawat1* and Nupoor Sharma2
1Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur (Raj.)
2B. N. Institute of Pharmaceutical Sciences, Udaipur (Raj.)
*Corresponding Author

Published In: Volume - 7, Issue - 1, Year - 2014

View HTML

View PDF

ABSTRACT:
India is becoming a hub for the availability and usage of banned/harmful medicines like Nimesulide, D’cold, Novalgin, Lomofen, Rofecoxib etc. A drug is banned on the basis of risk versus benefit ratio evaluated through post marketing surveillance and Adverse Drug Reaction Reporting System. Pharmaceutical negligence among doctors can lead to hazardous effects on the general health of a patient. The present study was planned to explore about awareness of banned drugs among educated youth and people related to this profession. Government should spread the information of drugs side effect. Doctors should not prescribe these drugs to protect the human health.

Keywords:

Cite this article:
Sunita Panchawat, Nupoor Sharma. The Scene of Banned Drugs in India. Research J. Pharm. and Tech. 7(1): Jan. 2014; Page 104-109.

Cite(Electronic):
Sunita Panchawat, Nupoor Sharma. The Scene of Banned Drugs in India. Research J. Pharm. and Tech. 7(1): Jan. 2014; Page 104-109. Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2014-7-1-14